Literature DB >> 8052971

Defibrotide stimulates expression of thrombomodulin in human endothelial cells.

Q Zhou1, X Chu, C Ruan.   

Abstract

Cultured human umbilical vein endothelial cells were incubated with defibrotide at concentrations of 0, 5, 50 and 500 micrograms/ml for 4 and 24 h respectively. Thrombomodulin activity and molecules on the surface of the cells were determined by chromogenic assay and radioimmunoassay, thrombomodulin antigen in endothelial cells and in conditioned medium of the cells was measured by immunoradioassay. Thrombomodulin mRNA within the cells was analysed by slot blot. After 24 h of incubation, the activity and molecules of thrombomodulin on the surface of endothelial cells, as well as the antigen and mRNA of thrombomodulin in the cells were significantly increased in a dose dependent manner. However, the level of thrombomodulin antigen in conditioned medium was about equal to that of the control. Our data indicate that defibrotide stimulates expression of thrombomodulin in human endothelial cells. These beneficial effects may play a role in antithrombotic activity of defibrotide.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8052971

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  9 in total

1.  Defibrotide: a Swiss Army knife intervention in the battle against cerebral malaria.

Authors:  Julie M Moore; John W Avery
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03       Impact factor: 8.311

Review 2.  Defibrotide: a review of its use in severe hepatic veno-occlusive disease following haematopoietic stem cell transplantation.

Authors:  Gillian M Keating
Journal:  Clin Drug Investig       Date:  2014-12       Impact factor: 2.859

3.  Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial.

Authors:  Paul G Richardson; Robert J Soiffer; Joseph H Antin; Hajime Uno; Zhezhen Jin; Joanne Kurtzberg; Paul L Martin; Gideon Steinbach; Karen F Murray; Georgia B Vogelsang; Allen R Chen; Amrita Krishnan; Nancy A Kernan; David E Avigan; Thomas R Spitzer; Howard M Shulman; Donald N Di Salvo; Carolyn Revta; Diane Warren; Parisa Momtaz; Gary Bradwin; L J Wei; Massimo Iacobelli; George B McDonald; Eva C Guinan
Journal:  Biol Blood Marrow Transplant       Date:  2010-02-16       Impact factor: 5.742

Review 4.  Novel antithrombotic drugs in development.

Authors:  M Verstraete; P Zoldhelyi
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

5.  Pharmacokinetics and Safety of Defibrotide in Healthy Japanese Subjects.

Authors:  Kazuo Umemura; Takayuki Iwaki; Toshimi Kimura; Chitose Ogawa; Takahiro Fukuda; Shuichi Taniguchi; Keizo Horibe; Hiroaki Goto; Kenichi Yoshimura; Yasutaka Watanabe; Chika Nitani; Atsushi Kikuta
Journal:  Clin Pharmacol Drug Dev       Date:  2016-05-06

6.  The Biological and Clinical Relevance of G Protein-Coupled Receptors to the Outcomes of Hematopoietic Stem Cell Transplantation: A Systematized Review.

Authors:  Hadrien Golay; Simona Jurkovic Mlakar; Vid Mlakar; Tiago Nava; Marc Ansari
Journal:  Int J Mol Sci       Date:  2019-08-09       Impact factor: 5.923

7.  Pre-Exposure to Defibrotide Prevents Endothelial Cell Activation by Lipopolysaccharide: An Ingenuity Pathway Analysis.

Authors:  Nicoletta Orlando; Gabriele Babini; Patrizia Chiusolo; Caterina Giovanna Valentini; Valerio De Stefano; Luciana Teofili
Journal:  Front Immunol       Date:  2020-12-03       Impact factor: 7.561

8.  Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide.

Authors:  Hui Shi; Alex A Gandhi; Stephanie A Smith; Qiuyu Wang; Diane Chiang; Srilakshmi Yalavarthi; Ramadan A Ali; Chao Liu; Gautam Sule; Pei-Suen Tsou; Yu Zuo; Yogendra Kanthi; Evan A Farkash; Jiandie D Lin; James H Morrissey; Jason S Knight
Journal:  JCI Insight       Date:  2021-09-08

Review 9.  The importance of endothelial protection: the emerging role of defibrotide in reversing endothelial injury and its sequelae.

Authors:  Paul G Richardson; Marta Palomo; Nancy A Kernan; Gerhard C Hildebrandt; Nelson Chao; Enric Carreras
Journal:  Bone Marrow Transplant       Date:  2021-09-28       Impact factor: 5.483

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.